To improve the development of targeted therapeutics for CRC, a quantitative understanding of the molecular and cellular events leading to aberrant colon crypt development (due to APC mutation) and the subsequent effects of oncogene mutation on the characteristics of CRC stem cells is essential11. This evidence concerns the gene APC and colorectal carcinoma.